Pathogenesis and treatment of liver fibrosis in alcoholics: 1996 update

Digestive Diseases

Volumn 15, Issue 1-2, 1997, Pages 42-66

  Lieber, Charles S ^a,b  

^a Section of Liver Disease and Nutrition and Alcohol Research   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; Antioxidants; Cirrhosis; Collagen; Collagenase; Dilinoleoylphosphatidyl choline; Liver; Phosphatidylcholine; Phospholipids; S Adenosylmethionine

Indexed keywords

1,2 LINOLEOYLPHOSPHATIDYLCHOLINE; 1,2-LINOLEOYLPHOSPHATIDYLCHOLINE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CARBON TETRACHLORIDE; COLCHICINE; COLLAGEN; LIPOSTABIL; PHOSPHATIDYLCHOLINE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; S ADENOSYLMETHIONINE;

ALCOHOL LIVER CIRRHOSIS; ANIMAL; CYTOLOGY; DISEASE COURSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; LIVER; METABOLISM; OXIDATIVE STRESS; PRIMATE; RAT; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CARBON TETRACHLORIDE; COLCHICINE; COLLAGEN; DISEASE PROGRESSION; HUMANS; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; PRIMATES; PROCOLLAGEN-PROLINE DIOXYGENASE; RATS; S-ADENOSYLMETHIONINE;

EID: 0030623722     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000171587     Document Type: Article

References (175)

1. Snell AM: Changing conceptions of portal cirrhosis, J Med 1941:22: 163-164.
2. Jolliffe N, Jcllinck EM: Vitamin deficiencies and liver cirrhosis in alcoholism, Part VII: Cirrhosis of the liver, Q J Stud Alcohol 1941:2:544-583.
3. Lelbach WK: Epidemiology of alcoholic liver disease; in Popper H, Schaffner E (eds): Progress in Liver Disease, New York, Grune & Stratton, 1976.
4. Stone WD, Islam NRK, Paton A: The natural history of cirrhosis, Q J Med 1968:37:119-132.
5. Hallen J, «.rook H: Follow-up studies on an unselected ten-year material of 360 patients with liver cirrhosis in one community, Acta Med Scand 1963:173:479-493.
6. Kliencbergcr C: Abdominaltyphus und Lebercirrhose, Z.entralb Inn Med 1923:44:129-124.
7. Kennedy JA: Psychosis with alcoholic pellagra, Med Bull Veterans Admin 1993:10:155-158.
8. Allan FN, Bowie DJ, MacLeod J.IR, Robinson WL: Behavior of dcpan-crealized dogs kept alive with insulin, BrJ Exp Pathol 1924:5:75-83.
9. du Vigneaud V, Chandler JP, Cohn M, Brown GB: flic transfer of methyl group from methionine to choline and creatine, J Biol Chem 1940:134: 787-788.
10. Connor CL: Fatly infiltration of the liver and the development ofcirrho-sis in diabetes and chronic alcoholism, Am J Pathol 1938:14:347-364.
11. Rich AR, Hamilton JD: Theexperi-mental production of cirrhosis of the liver by means of a deficient diet, Bull Johns Hopkins Hosp 1940:66: 185-198.
12. Daft FS, Sebrell WH, Lillie RD: Production and apparent prevention of a dietary liver cirrhosis in rats, Proc Soc Exp Biol Med 1941: 48:228-229.
13. Volwilcr W, Jones CM, Mallory TB: Criteria for the measurement of result of treatment in fatty cirrhosis, Gastroenterology 1948; 11:164-182.
14. Hartrofl WS: Diagnostic significance of fatty cysts in cirrhosis, AM A Arch Pathol 1953:55:63-69.
15. Weichselbaum TE: Cystine deficiency in albino rat, Q J Exp Physiol 1935:25:363-367.
16. Gyorgy P, Goldblalt H: Hepatic injury on a nutritional basis in rats, J Exp Med 1939:70:185-192.
17. Daft FS, Sebrell WH, Lillie RD: Prevention by cystine or methionine of hemorrhage and necrosis of ivcr in rats, Proc Soc Exp Biol Med 1942: 50:1-5.
18. Schwarz K: Tocopherol als Lcber-schutzstoff, Hoppe Scylers Z Physiol Chem 1944:281:109-116.
19. Nanji AA, French SW: Dietary lin-oleic acid is required for development of experimentally induced alcoholic liver injury, Life Sci 1989: 44:223-229.
20. Himsworth HP, Glynn LE: Massive hepatic necrosis and diffuse hepatic fibrosis (acute yellow atrophy and portal cirrhosis): Their production by means of a diet, Clin Sci 1944:5: 93-119.
21. Best CH, Hartroft WS, Lucas CS, Ridout JH: Liver damage produced by feeding alcohol or sugar and its prevention by choline, Br Med J 1949:2: 1001-1006.
22. Liebcr CS, Jones DP, DeCarli LM: Effects of prolonged ethanol intake: Production of fatty liver despite adequate diets, J Clin Invest 1965:44: 1009-1021.
23. Liebcr CS, Jones DP, Mendelson J, DeCarli LM: Fatty liver, hyperlipemia and hyperuricemia produced by prolonged alcohol consumption, despite adequate dietary intake, Trans Assoc Am Physicians 1963: 76:289-300.
24. DeCarli LM, Liebcr CS: Fatty liver m the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet, J Nutr 1967; 91:331-336.
25. Dich J, Bro B, Grunnct N, Jenscn F, Kondrup J: Accumulation oftriacvl-glvccrol in cultured rat hepatocytes is increased by ethanol and by insulin and dexamclhasone, Biochem J 1983;212:617-623.
26. Lieber CS, Rubin E: Alcoholic fatty liver in man on a high protein and low fat diet, Am J Med 1968:44: 200-206.
27. Tsukamoto H, French SW, Benson N, Delgado G, Rao GA, Larkin EC, Largman C: Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragas-tric infusion of ethanol and low fat diet, Hepatology 1985:5:224-232.
28. Lieber CS, DeCarli LM, Rubin E: Sequential production of fatty liver, hepatitis and cirrhosis in sub-human primates fed ethanol with adequate diets, Proc Natl Acad Sci USA 1975:72:437-441.
29. Lieber CS, Leo MA, Mak KM, DeCarli LM, Sato S: Choline fails to prevent liver fibrosis in ethanol-fed baboons but causes toxicity, Hepatology 1985:5:561-572.
30. Lieber CS, DeCarli LM, Mak KM, Kim CH, Leo MA: Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin, Hepatology 1990;12:1390-1398.
31. Lieber CS, Robins S, Li J, DeCarli LM, Mak KM, Fasulo JM, Leo MA: Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon, Gastroenterology 1994: 106:152-159.
32. Popper H, Lieber CS: Histogenesis of alcoholic fibrosis and cirrhosis in the baboon, Am J Pathol 1980:98: 695-716.
33. Ainley CC, Senapati A, Brown IMH, Lles CA, Slavin BM, Mitchell WE, Davies DR, Keeling PWN, Thompson RPH: Is alcohol hepato-toxic in the baboon? J Hepatol 1988: 7:85-92.
34. Simon D, Galamos JT: A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis, J Hepatol 1988:7:200-207.
35. Nakano M, Womer T, Lieber CS: Perivenular fibrosis in alcoholic liver injury: Ultrastructurc of histologic progression, Gastroenterology 1982:83:777-785.
36. Karasawa T, Kushida T, Shikata T, Kancda II: Morphologic spectrum of liver diseases among chronic alcoholics, Acta Pathol Jpn 1980:30: 505-514.
37. Khoruts A, Stahnke S, McClain CJ, Logan G, Allen JI: Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients, Hepatology 1991;13:267-276.
38. Sheron N, Bird G, Goka J, Alexander G, Williams R: Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis, Clin Exp Immunol 1991:84:449-453.
39. Greenwel P, Iraburu MJ, Rcyes-Rornero M, Mcraz-Cruz N, Casado E, Solis-Hcrru/.o JA, Rojkind M: Induction of an acute phase response in rats stimulates the expression of a I (I) procollagen messenger ribonucleic acid in their livers, Lab Invest 1995;72:83-91.
40. McClain C, Hill D, Schmidt J, Diehl AM: Cytokines and alcoholic liver disease, Semin Liver Dis 1993:13: 170-182.
41. Border WA, Noble NA: Transforming grow th factor 1 in tissue fibrosis, N Engl J Med 1994:19:1286-1292.
42. Castillo T, Koop DR, Kamimura S, Triadafilopoulos G, Tsukamoto II: Role of cytochrome P-450 2EI in ethanol-, carbon tetrachloride-and iron-dependent microsomal lipid peroxidation, Hepatology 1992:16: 992-996.
43. Anscher MS, Peters WP, Reiscn-bichler H, Petros WP, Jirtlc RL: Transforming growth factor-p as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer, N Engl J Med 1993:328:1592-1598.
44. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-pl underlies development of progressive kidney fibrosis, Kidney Int 1994;45:916-927.
45. Weiner FR, Esposti SD, Zern MA: A role for cytokines as regulators of hepatic fibrogenesis, Gastroenterol Jpn 1993:28 (suppl 4):97-101.
46. Czaja M, Xu J, Alt E: Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor, Gastroenterology 1995:108:1849-1854.
47. Helman RA, Temko MIL Nye SW, Fallon IIJ: Alcoholic hepatitis: Natural history and evaluation of prednisolone therapy, Ann Intern Med 1971:74:311-321.
48. Lesesne HR, Bozvmski EM, Fallon HJ: Liver physiology and disease, Treatment of alcoholic hepatitis with encephalopathy: Comparison of prednisolone with caloric supplements, Gastroenterology 1978:74: 169-173.
49. Maddrcy WC, Weber FL, Coulter AW, Chura CM, Chapanis NP, Walscr M: Effects of keto analogue essential amino acids in portal-svs-lemic encephalopathy, Gastroenterology 1978;71:190-195.
50. Carithcrs RL Jr, Herlong FH, Diehl AM, Shaw F.W, Combes B, Fallon HJ, Maddrcy WC: Mcthvlpredni-sone therapy in patients with severe alcoholic hepatitis, A randomized multiccnter trial, Ann Intern Med 1989; 110:685-690.
51. Ramond MJ, Poynard T, RuelTB: A randomized trial of prednisolone in patients with severe alcoholic hepatitis, N Engl J Med 1992:326:507-512.
52. Mendenhall CL, Anderson S, Garcia-Pont P, Goldberg S, Kieman T, Secit LB, Sorrell M, Tamburro C, Weesner R, Zctterman R, Chcdid A, Chen T, Rabin L: Short-term and long-term survival in patients with alcoholic hepatitis treated with ox-androloneand prednisolone, N Engl J Med 1984:311:1464-1470.
53. Kcrshcnobich D, Uribe M, Suarez G, Mata JM, Tamayo RP, Rojkind M: Treatment of cirrhosis with colchicine, A double-blind randomized trial, Gastroenterology 1979;77: 532-536.
54. Kershenobich D, Vargas F, Garcia-Tsao G, Tomayo RP, Gent M, Rojkind M: Colchicine in the treatment of cirrhosis of the liver, N Engl J Med 1988:318:1709-1713.
55. Boyer LJ, Ransohof TFD: Is colchicine effective therapy for cirrhosis? N Engl J Med 1988:318:1751-1752.
56. Paronetto F: Immunologic reactions in alcoholic liver disease, Semin Liver Dis 1993:13:183-195.
57. Rosman AS, Paronctto F, Galvin K, Williams RJ, Lieber CS: Hepatitis C virus antibody in alcoholic patients: Association with the presence of portal and/or lobular hepatitis, Arch Intern Med 1993;153:965-969.
58. Patrick RS: Alcohol as a stimulus to hepatic fibrogenesis.J Alcohol 1973: 8:13-27.
59. Mezey E, Potter JJ, Iber FL, Mad-drey WC: Hepatic collagen prolinc hydroxylase activity in alcoholic hepatitis: Effect of penicillamine, J UbClin Med 1979;93:92-100.
60. Mann SW, Fuller GC, Rodil JV, Vidins EI: Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease, Gut 1979:20:825-832.
61. Zern MA, Lai MA, Giambrone MA, Lieber CS: Increased type I procol-lagcn mRNA levels and in vitro protein synthesis in the baboon model of chronic alcoholic liver disease, Gastroenterology 1985:89: 1123-1131.
62. Mak KM, Leo MA, Lieber CS: Alcoholic liver injury in baboons: Transformation of lipocytes to transitional cells, Gastroenterology 1984: 87:188-200.
63. Mak Kl, Lieber CS: Lipocytes and transitional cells in alcoholic liver disease: A morphometrie study, Hepatology 1988;8:1027-1033.
64. Davis BH, Pratt BM, Madri JA: Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels, J Biol Chem 1987:162:10280-10286.
65. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM: Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix, J Biol Chem 1989:264:10756-10762.
66. Moshage H, Casini A, Lieber CS: Acetaldehyde stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocyles, Hepatology 1990:12:511-518.
67. Nakano M, Lieber CS: Ultrastructure of initial stages of perivcnular fibrosis in alcohol-fed baboons, Am J Pathol 1982;106:145-155.
68. Savolainen E-R, Leo MA, Timple R, Liebcr CS: Acetaldehyde and lactate stimulate collagen synthesis of cultured baboon liver myofibroblasts, Gastroenterology 1984:87:777-787.
69. Casini A, Cunningham M, Rojkind M, Liebcr CS: Acetaldehyde increases procollagcn type I and fi-bronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism, Hepatology 1991:13:758-765.
70. Casini A, Ceni E, Salzano R, Milani S, Schuppan D, Surrenti C: Acetaldehyde regulates the gene expression of matrix-metalloproteinase-l and-2 in human fat-storing cells, Life Sci 1994;55:1311-1316.
71. Finkclstein JD, Martin JJ: Methionine metabolism in mammals, Adaptation to methionine excess, J Biol Chem 1986:261:1582-1587.
72. Horowitz JH, Rvpins EB, Henderson JM, Heymsfield SB, Moffit SD, Bain RP, Chawla RK, Bleicr JC, Rudman D: Evidence for impairment of transsulfuration pathway in cirrhosis, Gastroenterology 1981; 81:668-675.
73. Duce AM, Ortiz P, Cabrerò C, Mato JM: S-Adenosvl-/.-mcthionine synthetase and phospholipid methyl-transferase are inhibited in human cirrhosis, Hepatology 1988:8:65-68.
74. Liebcr CS, Casini A, DeCarli LM, Kim C, Lowe N, Sasaki R, Leo MA: S-Adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon, Hepatology 1990:11: 165-172.
75. Yamada S, Mak KM, Lieber CS: Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase, Gastroenterology 1985:88: 1799-1806.
76. Corrales F, Gintenez A, Alvercz L, Caballeria J, Pajaares MA, Andreu H, Pares A, Mato JE, Rodcs J: S-Adenosylmethionine treatment prevents carbon tetrachloride-induced S-adcnosylmcthionine synthetase inactivation and attenuates liver injury', Hepatology 1992; 16:1022-1027.
77. Vendemiale G, Altomare E, Trizzio T, Le Grazzie C, DiPadova C, Salerno T, Carrieri V, Albano O: Effects of oral S-adcnosyl-methioninc on hepatic glutathione in patients with liver disease, Scand J Gastroenterol 1989:24:407-415.
78. Liebcr CS: Prevention and therapy with S-adenosyl-L-methionine and polyenylphosphatidylcholine: in Arroyo V, Bosch J, Rodes J (eds): Treatments in Hepatology, Paris, Masson, 1995, pp 299-311.
79. Shaw S, Jayatilleke E, Ross WA, Gordon ER, Liebcr CS: Ethanol induced lipid peroxidation: Potentiation by long-term alcohol feeding and attenuation by methionine, .J Lab Clin Med 1981:98:417-425.
80. Dai Y, Rashba-Step J, Ccderbaum AI: Stable expression of human cytochrome P4502EI in HcpG2 cells: Characterization of catalytic activities and production of reactive oxygen intermediates, Biochem J 1993: 32:6928-6937.
81. Hultberg B, Berglund M, Andcrsson A, Frank A: Elevated plasma homocysteine in alcoholics, Alcohol Clin Exp Res 1993:17:687-689.
82. Shaw S, Rubin KP, Lieber CS: Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease: Evidence of lipid peroxidation, Dig Dis Sci 1983:28: 585-589.
83. Morton S, Mitchell MC: Effects of chronic ethanol feeding on glutathione turnover in the rat, Biochem Pharmacol 1985:34:1559-1563.
84. Speisky H, MacDonald A, Giles G, Orrego H, Israel Y: Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration, Biochem J 1985:225: 565.
85. Hirano T, Kaplowitz N, Tsukamoto H, Kamimura S, Fcrnandez-Checa JC: Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats, Hepatology 1992:6:1423-1427.
86. Barclay LR: The cooperative antioxidant role of glutathione with a lipid-soluble and a water-soluble antioxi-dant during peroxidation of liposomes initiated in the aqueous phase and in the lipid phase, J Biol Client 1988:263:16138-16142.
87. Geesin JC, Hendricks LJ, Falken-stcin PA, Gordon JS, Berg RA: Regulation of collagen synthesis by ascorbic acid: Characterization of the role of ascorbatc-stimulated lipid peroxidation, Arch Biochem Bio-phys 1991:290:127-132.
88. Tsukamoto H: Oxidative stress, an-lioxidants, and alcoholic liver fibro-genesis, Alcohol 1993; 10:465-467.
89. Tribble DL, Au TY, Jones DP: The pathological significance of lipid peroxidation in oxidative cell injury, Hepatology 1987:7:377-387.
90. Bonjour JP: Vitamins and alcoholism, Int J Vitant Nutr Res 1979:49: 434-441.
91. Korpela H, Kuntpulainen J, Luonta PV, Arranto AJ, Sotaniemi EA: Decreased serum selenium in alcoholics as related to liver structure and function, Am J Clin Nutr 1985:42: 147-151.
92. Dworkin B, Rosenthal WS, Jankowski RH, Gordon GG, Haldca D: Low blood selenium levels in alcoholics with and without advanced liver disease, Dig Dis Sci 1985:30: 838-844.
93. Tanner AR, Bantock I, Hinks L, Lloyd B, Turner NR, Wright R: Depressed selenium and vitamin E levels in an alcoholic population: Possible relationship to hepatic injury through increased lipid peroxidation, Dig Dis Sci 1986:31:1307-1312.
94. Losowsky MS, Leonard PJ: Evidence of vitamin E deficiency in patients with malabsorption or alcoholism and the effect of therapy, Gut 1967:8:539-543.
95. Yoshikawa Y, Takemura S, Kondo M: u-Tocopherol level in liver diseases, Acta Vitaminol Enzvmol 1982:4:311-318.
96. Bjorneboc GEA, Johnsen J, Bjornc-boe A, Morland J, Drcvon CA: Effect of heavy alcohol consumption on serum concentration of fat soluble vitamins and selenium, Alcohol Alcohol Suppl 1987;1:533-537.
97. McCay PB: Vitamin E interaction with free radical and ascorbatc, Annu Rev Nutr 1985:5:323-340.
98. Niki E: Interaction of ascorbale and a-tocopherol, Ann NT Acad Sci 1987;493:186-199.
99. Bjorneboc GEA, Bjorneboc A, Hagen BF, Morland J, Drcvon CA: Reduced hepatic a-tocopherol content after long-term administration of ethanol to rats, Biochint Biophys Acta 1987;918:236-241.
100. Bjorneboc GEA, Johnsen J, Bjor-neboe A, Markulund SL, Skylv N, Hoiscth A, Bache-Wiig JE.’ Morland J, Drcvon CA: Some aspects of antioxidant status in blood Iront alcoholics, Alcohol Clin Exp Res 1988:12:806-810.
101. Leo MA, Aleynik S, Aleynik M, Lieber CS: Hcpalotoxicitv of alcohol is potentiated by ß-carotenc bcadlets (abstract), Gastroenterology 1995:108:1109.
102. Kamimura S, Gaal K, Britlon RS, Bacon BR, Triadafilopoulos G, Tsukamoto H: Increased 4-hy-droxynoncnal levels in experimental alcoholic liver disease: Association of lipid peroxidation with liver fibrogcncsis, Hepatology 1992: 16:448-453.
103. Leo MA, Rosman A, Lieber CS: Differential depletion of carot-enoids and tocopherol in liver diseases, Hepatology 1993:17:977-986.
104. Kawase T, Kalo S, Lieber CS: Lipid peroxidation and antioxidanl defense systems in rat liver after chronic ethanol feeding, Hepatology 1989:10:815-821.
105. Dicker E, Cederbaum AI: Increased oxygen radical-dependent inactivation of metabolic enzymes by liver microsomes alter chronic ethanol consumption, FASEB J 1988:2:2901-2906.
106. Chojkier M, Houglum K, Solis-Herruzo J, Brenner DA: Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblast, A role for lipid peroxidation? J Biol Chcm 1989:264: 16957-16962.
107. Houglum K, Filip M, Witztun JL, Chojkier M: Malondialdehvdeand 4-hydroxynoncnal protein adducts in plasma and liver of rats with iron overload, J Clin Invest 1990: 86:1991-1998.
108. Lieber CS: The influence of alcohol on nutritional status, Nutr Rev 1988:46:241-245.
109. Zhang H, Loncy LA, Potter BJ: Effect of chronic alcohol feeding on hepatic iron status and ferritin uptake by rat hépatocytes, Alcohol Clin Exp Res 1993;17:394-400.
110. Scitz HK, Poschl G: Antioxidant drugs and colchicine in the treatment of alcoholic liver disease; in Arroyo V, Bosch J, Rodes J (eds): Treatments in Hepatology, Barcelona, Masson, 1995, pp 271-276.
111. Leo MA, Lieber CS: Hepatic vitamin A depletion in alcoholic liver injury, N Engl J Med 1982:307: 597-601.
112. Sato M, Lieber CS: Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats, J Nutr 1981:111:2015-2023.
113. Leo MA, Lieber CS: New pathway for retinol metabolism in liver nti-erosomes, J Biol Chem 1985:260: 5228-5231.
114. Leo MA, Kim C, Lieber CS: NAD’-dependent retinol dehydrogenase in liver microsomes, Arch Biochcm Biophys 1987:259:241-249.
115. Leo MA, Iida S, Lieber CS: Retino-ic acid metabolism by a system reconstituted with cytochrome P-450, Arch Biochent Biophys 1984; 234:305-312.
116. Leo MA, Lasker JM, Raucy IL, et al: Metabolism of retinal and rcti-noic acid by human liver cytochrome P450IIC8, Arch Biochent Biophys 1989:269:305-312.
117. Leo MA, Lowe N, Lieber CS: Potentiation of ethanol-induced hepatic vitamin A depletion by phénobarbital and butylatcd hvdroxy-toluenc, J Nutr 1987:117:70-76.
118. Leo MA, Lowe N, Lieber CS: De-crcscd hepatic vitamin A after drug administration in men and in rats, Am J Clin Nutr 1984:40: 1131-1136.
119. Leo MA, Sato M, Lieber CS: Effect of hepatic vitamin A depletion on the liver in humans and rats, Gastroenterology 1983:84:562-572.
120. Leo VIA, Lowe N, Lieber CS: Interaction of drugs and retinol, Biochem Pharmacol 1986:35:3949-3953.
121. Bachem MG, Meyer D, Melchior R, Sell K-.M, Gressner AM: Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from mvofibroblasl-like cells: A potential mechanism of self perpetuation in liver fibro-genesis, J Clin Invest 1992:89:19-27.
122. Friedman SI, Wei S, Blaner WS: Retinol release by activated rat hepatic lipocytes: Regulation by Kupffer cell-condition medium and BDGF, Am J Physiol 1993: 264:G947-G952.
123. Leo MA, Lieber C’S: Hypcrvita-minosis A: A liver lover’s lament, Hepatology 1988:8:412-417.
124. Stimson WH: Vitamin A intoxication in adults, Report of a ease with a summary of the literature, N Engl J Med 1961:265:369-373.
125. Josephs HW: Hypervitaminosis A and earotenemia, Am J Dis Child 1944:6733-6743.
126. Muenter MD, Perry HO, Ludwig J: Chronic vitamin A intoxication in adults: Hepatic, neurologic and dermalologic complications, Am J Med 1971:50:129-136.
127. Russell RM, Boyer JL, Baheri SA, et al: Hepatic injury from chronic hypervitaminosis A resulting in portal hypertension and ascites, N Engl J Med 1974:291:435-440.
128. Jacques EA, Buschmann RJ, Lavden TJ: The histopathologic progression of vitamin A-induced hepatic injury', Gastroenterology 1979;76:599-602.
129. Hruban Z, Russell RM, Boyer JL, et al: Ultrastructural changes in livers of two patients with hypervitaminosis A, Am J Pathol 1974:76: 451-468.
130. Minuk GY, Kelly JK, Hwang WS: Vitamin A hepatotoxicity in multiple family members, Hepatology 1988:8:272-275.
131. McLaren DS: The luxus vitamins: A and B2, Am J Clin Nutr 1981: 34:1611-1616.
132. Weber FL, Mitchell GE Jr., Powell DE, et al: Reversible hcpatotoxici-tv associated with hepatic vitamin A accumulation in a protein-deficient patient, Gastroenterology 1982:82:118-123.
133. Leo MA, Arai M, Sato M, Lieber CS: Hepatotoxicity of vitamin A and ethanol in the rat, Gastroenterology 1982;82:194-205.
134. Leo MA, Lieber CS: Hepatic fibrosis after long term administration of ethanol and moderate vitamin A supplementation in the rat, Hcpatology 1983;2:1-11.
135. Li J-J, Kim CJ, Leo MA, Mak KM, Rojkind M, Lieber CS: Polyunsaturated lecithin prevents acct-aldehyde-mediated hepatic collagen accumulation by stimulating eollagenase activity in cultured lipocytes, Hepatology 1992; 15:373-381.
136. Lieber CS: Medical and Nutritional Complications of Alcoholism: Mechanisms and Management, New York, Plenum Press, 1992, p 579.
137. Maruvama K, Feinntan L, Okazaki I, Lieber CS: Direct measurement of neutral eollagenase activity in homogenates from baboon and human liver, Biochim Biophvs Acta 1981:658:124-131.
138. Maruvama K, Feinntan L, Faina-ko M, Okazaki I, Lieber CS: Mammalian eollagenase increase in early alcoholic liver diseases and decreases with cirrhosis, Life Sci 1982:30:1379-1384.
139. Li J-J, Rosntan AS, Leo MA, Nagai Y, Lieber CS: Tissue inhibitor of metalloprotcinasc is increased in the serum of prccirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis, H epa-tology 1994:19:1418-1423.
140. Weiner FR, Eskreis D, Compton KV, Orrego H, Zern MA: Haplo-tvpe analysis of type I collagen gene and its association with alcoholic cirrhosis in man, Mol Aspects Med 1988:10:159-168.
141. Bashir R, Day CP, James OFW, Ogilvic DJ, Svkcs B, Basscndinc MF: No evidence for involvement of type I collagen structural genes in ’genetic predisposition’ to alcoholic cirrhosis, J Hepatol 1992:16: 316-319.
142. Womer TM, Lieber CS: Perivenu-lar fibrosis as precursor lesion of cirrhosis, JAMA 1985:254:627-630.
143. Litten R, Allen J: Measuring Alcohol Consumption: Psychosocial and Biochemical Methods, Toto-wa, Humana, 1992.
144. Rosman AS, Lieber CS: Biochemical markers of alcohol consumption, Alcohol Health Res World 1990;14:210-218.
145. Stibler H, Borg S, Joustra M: Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish Patent 8400587-5), Alcohol Clin Exp Res 1986:10:534-544.
146. Behrens IIJ, Woerner TM, Braly LF, Schafiner F, Lieber CS: Carbohydrate-deficient transferrin (CDT), a marker for chronic alcohol consumption in different ethnic populations, Alcohol Clin Exp Res 1988:12:427-432.
147. Orrego H, Medline A, Blendis LM, Rankin JG, Krcadcn DA: Collagen isat ion of the Disse space in alcoholic liver disease, Gut 1979: 20:673-679.
148. Mak KM, Lieber CS: Alterations in endothelial fenestrations in liver sinusoids of baboons fed alcohol: A scanning electron microscopic study, Hepatology 1984:4:386-391.
149. Miyakawa H, lida S, Leo MA, Grccnstcin RJ, Zimmon DS, Lieber CS: Pathogenesis of precirrhotic portal hypertension in alcohol-fed baboons, Gastroenterology 1985:88:143-150.
150. Arai M, Gordon ER, Lieber C’S: Decreased cytochrome oxidase activity in hepatic mitochondria after chronic ethanol consumption and the possible role of decreased cytochrome aaj content and changes in phospholipids, Biochim Biophvs Acta 1984:797:320-327.
151. Sundler R, Akcsson B: Regulation of phospholipid biosynthesis in isolated rat hepatocytcs, J Biol Client 1975:250:3359-3367.
152. Lieber CS, Robins SJ, Leo MA: Hepatic phosphatidylethanolamine mcthyltransfcrase activity is decreased by ethanol and increased by phosphatidylcholine, Alcohol Clin Exp Res 1994:18:592-595.
153. Lieber C’S, Li JL Robins S, DeCarli LM, Mak KM, Leo MA: Dietary dilinoleoylphosphatidyl-choline (DLPC) is incorporated into liver phospholipids, protects against alcoholic cirrhosis, enhances collage-nase activity and prevents acctal-dchyde-induced collagen accumulation in cultured lipocytes (abstract), Hepatology 1992; 16:87.
154. Fox JM: Polyene phosphatidylcholine, Pharmacokinetics after oral administration: A review; in Avogaro P, Macini M, Ricci G, Paolctti R (eds): Phospholipids and Atherosclerosis, New York, Raven Press, 1983.
155. Ziercnbcrg O, Grundy SM: Intestinal absorption of polycnylphos-phatidylcholine in man, J Lipid Res 1982;23:1136-1142.
156. Parthasarathy S, Subbaiah PV, Ganguly J: The mechanism of intestinal absorption of phosphatidylcholine in rats, Biochem J 1974:140:503-508.
157. Rodgers JB, O'Brien RJ, Balint JA: The absorption and subsequent utilization of lecithin by the rat jejunum, Am J Dig Dis 1975:20: 208-211.
158. Lekim D, Betzing H: The incorporation of essential phospholipids into the organs of intact and galac-tosamine intoxicated rats, Drug Res 1974;24:1217-1221.
159. Amesjo B, Nilsson A, Barrowman J, Borgstrom B: Intestinal digestion and absorption of cholesterol and lecithin in the human: Intubation studies with a fat-soluble reference substance, Scand J Gastroenterol 1969:4:653-655.
160. Nilsson AKE: Intestinal absorption of lecithin and lysolccithin by lymph fistula rats, Biochim Bio-physActa 1968:152:379-390.
161. Patton GM, Clark SB, Fasulo JM, Robins SJ: Utilization of individual lecithins in intestinal lipoprotein formation in the rat, J Clin Invest 1984;73:231-240.
162. 2P-Polycnephosphatidyl-cholin in die Leber von Ratten und Scine Ausscheidung durch die Galle, Z Naturforsch 1971:26:1151-1158.
163. Ixkim D, Betzing H, Stoffel W: Incorporation of complete phospholipid molecules in cellular membranes of rat liver after uptake from blood serum, Hoppe Seylers Z Physiol Chem 1972: 353S:929-946.
164. Lekim D, Graf E: Tierexperimen-telle Studien zur Pharmakokinetik der «essentiellen» Phospholipide (F.PL), Arzneimitlelforschung 1976;26:1772-1782.
165. Lieber CS, DeCarli IM: An experimental model of alcohol feeding and liver injury in the baboon, J Med Printatol 1974:3:153-163.
166. Foy II, Kondi A, Mbava V: Effect of riboflavine deficiency on bone marrow function and protein metabolism in baboon, Br J Nutr 1964:18:307-318.
167. Alliet J, C'omlan G, Gourdicr D: Steatosis of the human hepatocytc: An ultrastructure study of the reparative effects of polyenic fatty acid phosphatidylcholines, Ouest Med 1976:29:85-104.
168. Fassati P, Horejsi J, Fassati M, Spizck J, Jczkova Z: Essential choline phospholipids and their effect on HBsAG and selected biochemical tests in cirrhosis of the liver, Casopis Lekaru Ceskych 1981: 120:56-60.
169. Bird GLA, Panos MZ, Poison R, Johnson R, Portman B, Neuberger J, Williams R: Activity of polyunsaturated phosphatidylcholine in HBsAG negative chronic active hepatitis and acute alcoholic hepatitis, Z Gastroenterol 1991; 29(suppl 2):21-24.
170. Schüller-Pérez A, Gonzáles-San Martin F: Kontrollierte Studie mit mehrfach ungesättigtem Phospha-tidylcholin im Vergleich zu Plazebo bei alkoholischer Leberstcatose, Med Welt 1985:36:517-521.
171. Ma X, Zhao J, Lieber CS: Poly-cnylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression, J Hepatol 1996:24(in press).
172. Rojkind M: Fibrogenesis in cirrhosis, Potential for therapeutic intervention, Pharmacol Thcr 1992:53: 81-104.
173. Wu J, Danielsson A: Inhibition of hepatic fibrogenesis: A review of pharmacological candidates, Scand J Gastroenterol 1994:29; 385-391.
174. Keiding S, Badsberg JH, Becker U, Bcntsen KD, Bonncvic O, Caballería J, Eriksen J, Hardt F, Keiding N, Morgan M, Poulsen H, Ranek L, Rodes J, Schou G, Walker R, Tygstrup N: The prognosis of patients with alcoholic liver disease, An international randomized, placebo-controlled trial on the effect of malotilate on survival, J Hepatol 1994:20:454-460.
175. Friedman SL: Acetaldehyde and alcoholic fibrogenesis: Fuel to fire but not the spark, Hepatology 1990:12:690-691.